Table 2.

Effect of Concanamycin A on the percentage of mortality in Tax-positive or -negative cells

Patient Tax-negative CellsTax-positive Cells
TAN  
 −Concanamycin A  1.0  40.0 
 +Concanamycin A  4.6  18.6  
HAW  
 −Concanamycin A 2.0  22.0  
 +Concanamycin A  3.8  12.0 
Patient Tax-negative CellsTax-positive Cells
TAN  
 −Concanamycin A  1.0  40.0 
 +Concanamycin A  4.6  18.6  
HAW  
 −Concanamycin A 2.0  22.0  
 +Concanamycin A  3.8  12.0 

Peripheral blood mononuclear cells were isolated from an asymptomatic carrier (HAW) of the human T-cell leukemia virus type I (HTLV-I) and a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (TAN), cultivated for 24 hours in the presence (+) or in the absence (−) of 20 nmol/L Concanamycin A, and then processed to perform the concomitant detection of Tax and propidium iodide, used to determine the percentage of mortality as described in “Materials and Methods.”

Close Modal

or Create an Account

Close Modal
Close Modal